Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- VHB-RCTIndependent statistical analysis of Virtual Hope Box - Effectiveness of a Smartphone App for Coping With Suicidal Ideation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ViBone in Cervical and Lumbar Spine Fusion: Complete Statistical AnalysisIndependent statistical analysis of ViBone in Cervical and Lumbar Spine Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03425682).
- Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01394250).
- VICARESIndependent statistical analysis of A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements: Complete Statistical AnalysisIndependent statistical analysis of VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VICTASIndependent statistical analysis of Vitamin C, Thiamine, and Steroids in Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03509350).
- VICTORIndependent statistical analysis of Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VICTOR-E1Independent statistical analysis of Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VICTOSIndependent statistical analysis of Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Vidaza to Restore Hormone Thx Prostate: Complete Statistical AnalysisIndependent statistical analysis of Vidaza to Restore Hormone Thx Prostate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00384839).
- Vigabatrin for Treatment of Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Vigabatrin for Treatment of Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00611130).
- VIH-2Independent statistical analysis of Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VIISTAIndependent statistical analysis of Veterans Inpatient Insulin Study and Transition to Outpatient Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00821795).
- VIKING-3Independent statistical analysis of A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vilazodone for Corticosteroid-Induced Memory Impairment: Complete Statistical AnalysisIndependent statistical analysis of Vilazodone for Corticosteroid-Induced Memory Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01828515).
- VillageWhereIndependent statistical analysis of Using Mobile Technology to Enhance Multisystemic Therapy (MST) Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02320903).
- Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing’s Sarcoma Family of Tumors: Complete Statistical AnalysisIndependent statistical analysis of Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vinegar Co-ingestion in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Vinegar Co-ingestion in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01279317).
- Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VIOLETIndependent statistical analysis of A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VIOLETIndependent statistical analysis of Vitamin D to Improve Outcomes by Leveraging Early Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03096314).
- VIPIndependent statistical analysis of Vanderbilt ICU Recovery Program Pilot Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03124342).
- VIPIndependent statistical analysis of Vascular Inflammation in Psoriasis Trial (The VIP Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01553058).
- VIP-HANAIndependent statistical analysis of Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03182738).
- Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV: Complete Statistical AnalysisIndependent statistical analysis of Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04364178).
- Virtual Human Technology for Patients With Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Virtual Human Technology for Patients With Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04349033).
- Virtual Reality Distraction During Outpatient Pediatric Orthopedic Procedures: Complete Statistical AnalysisIndependent statistical analysis of Virtual Reality Distraction During Outpatient Pediatric Orthopedic Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05510232).
- Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot: Complete Statistical AnalysisIndependent statistical analysis of Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05546749).
- Virtual Reality Guided Acupuncture Imagery Treatment for Chronic Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Virtual Reality Guided Acupuncture Imagery Treatment for Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Virtual Reality Mobility Training System for Veterans With Vision Loss: Complete Statistical AnalysisIndependent statistical analysis of Virtual Reality Mobility Training System for Veterans With Vision Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00333879).
- Virtual Reality Treatment for Adults With Chronic Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Virtual Reality Treatment for Adults With Chronic Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04468074).
- Virtual Reality Treatment for Emerging Adults With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Virtual Reality Treatment for Emerging Adults With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06454604).
- Virtual vs. Traditional Physical Therapy Following Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Virtual vs. Traditional Physical Therapy Following Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02914210).
- VIRTUSIndependent statistical analysis of VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses: Complete Statistical AnalysisIndependent statistical analysis of Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit: Complete Statistical AnalysisIndependent statistical analysis of Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02863809).
- VisipaqueIndependent statistical analysis of Comparison of Contrast Agents During CT Angiography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534975).
- Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma: Complete Statistical AnalysisIndependent statistical analysis of Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00939484).
- VISTAIndependent statistical analysis of Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ViStAIndependent statistical analysis of Violence and Stress Assessment (ViStA) Project to Improve Post Traumatic Stress Disorder Management in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens: Complete Statistical AnalysisIndependent statistical analysis of Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Visual Performance of Senofilcon A With and Without a New UV/HEV-filter: Complete Statistical AnalysisIndependent statistical analysis of Visual Performance of Senofilcon A With and Without a New UV/HEV-filter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Visual Performance of Soft Contact Lenses With Myopia Control Optics: Complete Statistical AnalysisIndependent statistical analysis of Visual Performance of Soft Contact Lenses With Myopia Control Optics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05141448).
- Visual Restoration for Hemianopia: Complete Statistical AnalysisIndependent statistical analysis of Visual Restoration for Hemianopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03350919).
- Visual Surround Suppression and Perceptual Expectation Under Psilocybin: Complete Statistical AnalysisIndependent statistical analysis of Visual Surround Suppression and Perceptual Expectation Under Psilocybin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04424225).
- VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia: Complete Statistical AnalysisIndependent statistical analysis of VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vita-ShockIndependent statistical analysis of Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02786498).
- VITALIndependent statistical analysis of A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- VITALIndependent statistical analysis of VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…